🔎 Trials Near Me

Pradžia › Opinis kolitas › Misūris › St. Louis

Opinis kolitas klinikiniai tyrimai St. Louis, MO

13 tyrimai dėl Opinis kolitas ieško dalyvių vietose St. Louis ir aplinkui (apytiksliai 30 mylių spinduliu). Atidarykite tyrimą, kad pamatytumėte, kas gali dalyvauti ir kaip susisiekti su tyrimo komanda.

Oficialus tyrimo tekstas (anglų kalba)

Ieškote dalyvių tyrimui? Pateikite jį šio puslapio viršuje – $99 už 30 dienų →

Study of Advanced Therapies for the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease or Ulcerative Colitis

Renkami dalyviai2 fazė
  • Specialists In Gastroenterology /ID# 283939, St Louis
Amžius nuo 18 iki 75 · Visoms lytims · Atnaujinta 2026-10-02 · NCT07697456

A Study of Vedolizumab in Adults With Ulcerative Colitis (UC) or Crohn's Disease (CD) in the Community Setting

Renkami dalyviai4 fazė
  • SSM Health Medical Group, Bridgeton · už 15 mylių
Amžius nuo 18 iki 80 · Visoms lytims · Atnaujinta 2026-09-30 · NCT06581328

A Trial to Investigate PALI-2108 Versus Placebo in Participants With Moderately to Severely Active Ulcerative Colitis

Renkami dalyviai2 fazė
  • Site US-006, St Louis
Amžius nuo 18 iki 75 · Visoms lytims · Atnaujinta 2026-09-29 · NCT07845487

A Study Investigating Oral Ozanimod (RPC1063) in Pediatric Participants With Moderate to Severe Active Ulcerative Colitis

Renkami dalyviai2/3 fazė
  • Washington University, St Louis
Amžius nuo 2 iki 17 · Visoms lytims · Atnaujinta 2026-09-24 · NCT05076175

Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study

Renkami dalyviai3 fazė
  • Washington University School of Medicine, St Louis
Amžius nuo 18 iki 70 · Visoms lytims · Atnaujinta 2026-09-24 · NCT06937086

Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO

Renkami dalyviai1 fazė
  • Washington University School of Medicine, St Louis
  • Siteman Cancer Center-South County, St Louis
  • Siteman Cancer Center at Christian Hospital, St Louis
  • ir dar 1
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-09-23 · NCT03816345

LY4268989 (MORF-057) Co-Administered With Mirikizumab in Adults With Moderately to Severely Active Ulcerative Colitis:

Renkami dalyviai2 fazė
  • Center for Gastrointestinal Health - Fairview Heights, Belleville · už 14 mylių
Amžius nuo 18 iki 80 · Visoms lytims · Atnaujinta 2026-09-22 · NCT07186101

A Master Protocol (IIBD): A Study of Multiple Drugs in Adults With Ulcerative Colitis or Crohn's Disease

Renkami dalyviai2 fazė
  • KAD Clinical Research, St Louis
Amžius nuo 18 iki 80 · Visoms lytims · Atnaujinta 2026-09-22 · NCT07483073

A Master Protocol (AMAZ): A Study of Mirikizumab (LY3074828) in Pediatric Participants With Ulcerative Colitis or Crohn's Disease (SHINE-ON)

Renkami dalyviai3 fazė
  • Washington University School of Medicine, St Louis
Amžius nuo 2 iki 19 · Visoms lytims · Atnaujinta 2026-09-22 · NCT04844606

LY4268989 in Adults With Moderately to Severely Active Ulcerative Colitis

Renkami dalyviai2 fazė
  • KAD Clinical Research, St Louis
  • Specialists in Gastroenterology, St Louis
Amžius nuo 18 iki 80 · Visoms lytims · Atnaujinta 2026-09-22 · NCT07415044

A Study of Vedolizumab With Tofacitinib in Adults With Ulcerative Colitis (UC)

Renkami dalyviai4 fazė
  • Washington University School of Medicine, St Louis
Amžius nuo 18 iki 65 · Visoms lytims · Atnaujinta 2026-09-21 · NCT06095128

BOOM-IBD2 Pivotal Clinical Trial

Renkami dalyviai
  • Gateway GI Research (Objective Health), St Louis
Amžius nuo 18 iki 85 · Visoms lytims · Atnaujinta 2026-08-06 · NCT06571669

A Phase 2 Study to Evaluate Therapies for Inflammatory Bowel Disease

Renkami dalyviai2 fazė
  • Mirador Therapeutics Selected Site, Bridgeton · už 15 mylių
Amžius nuo 18 iki 80 · Visoms lytims · Atnaujinta 2026-03-12 · NCT07113522

Opinis kolitas tyrimai kituose miestuose

Kiti tyrimai St. Louis

Iš ClinicalTrials.gov, duomenys gauti 2026-10-05. Kiekvienas tyrimas nustato savo tinkamumo kriterijus; tyrimo komanda sprendžia, kas gali dalyvauti.